We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Dyno Therapeutics

News List

Roche signs deal with Dyno Therapeutics for gene therapy vectors pharmatimes
October 16, 2020
Roche has signed a collaborative agreement with Dyno Therapeutics for the development of adeno-associated virus (AAV) vectors for gene therapies for central nervous system (CNS) disease and liver-directed therapies.
Sarepta and Dyno Therapeutics Will Develop Next-Gen Gene Therapy Vectors contractpharma
May 13, 2020
Dyno’s proprietary CapsidMap platform opens up new ways to identify novel capsids.
Dyno Therapeutics launches with deals from Novartis and Sarepta pharmaceutical-technology
May 13, 2020
Biotechnology company Dyno Therapeutics has launched from stealth mode with focus on using artificial intelligence (AI) technology to develop adeno-Associated Virus (AAV) vectors.